NYSE · Healthcare · Medical Care Facilities · USA
DaVita Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Care Facilities industry.
DaVita is a healthcare provider specializing in kidney care services. The company operates a U.S. dialysis business treating patients with end-stage kidney disease, international dialysis operations across multiple countries, and an integrated kidney care business providing disease management services. DaVita serves patients across various care settings including outpatient dialysis centers, hospitals, and home-based treatment options.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the DaVita Inc stock.
Undervalued: intrinsic value $407.70 per share, market price $187.00, margin of safety 54.1% (as of 2026-10-19).
Discounting its cash flows at 7.6% (average of 3 methods) values the shares at $407.70; the price of $187.00 is 54% below that value, and 81% of that value comes from beyond year five.
Leak Score: 92/100 on 10 of 12 signals (Major Leak).
17 more funds hold it; the full list is part of the paid plan.
All 48 Medical Care Facilities stocks
DVA is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 7.6% (average of 3 methods) values the shares at $407.70; the price of $187.00 is 54% below that value, and 81% of that value comes from beyond year five.
$407.70 per share (as of the 2026-10-19 close), against a market price of $187.00. That is a margin of safety of 54.1%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
92 out of 100, which we rate "Major Leak", on 10 of 12 value investing signals.